Abstract:Background and aims: To identify and validate N-glycan biomarkers in gastric cancer (GC) and to elucidate their underlying molecular mechanism of action. Methods: In total, 347 individuals, including patients with GC (gastric cancer) or atrophic gastritis and healthy controls, were randomly divided into a training group (n=287) and a retrospective validation group (n=60). Serum N-glycan profiling was achieved with DNA sequencer-assisted/fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). Two diagnostic models were constructed based on the N-glycan profiles using logistic stepwise regression. The diagnostic performance of each model was assessed in retrospective, prospective (n=60), and follow-up (n=40) cohorts. Lectin blotting was performed to determine total core-fucosylation, and the expression of genes involved in core-fucosylation in GC was analyzed by reverse transcriptase-polymerase chain reaction. Results: We identified at least 9 N-glycan structures (peaks) and the levels of core fucose residues and fucosyltransferase were significantly decreased in GC. Two diagnostic models, designated GCglycoA and GCglycoB, were constructed to differentiate GC from control and atrophic gastritis. The areas under the receiver operating characteristic (ROC) curves (AUC) for both GCglycoA and GCglycoB were higher than those for CEA, CA19-9, CA125 and CA72-4. Compared with CEA, CA19-9, CA125 and CA72-4, the sensitivity of GCglycoA increased 29.66%, 37.28%, 56.78% and 61.86%, respectively, and the accuracy increased 10.62%, 16.82%, 25.67% and 28.76%, respectively. For GCglycoB, the sensitivity increased 27.97%, 35.59%, 55.09% and 60.17% and the accuracy increased 21.26%, 24.64%, 31.40% and 34.30% compared with CEA, CA19-9, CA125 and CA72-4, respectively. After curative surgery, the core fucosylated peak (peak 3) and the total core fucosylated N-glycans (sumfuc) were reversed. Conclusions: The results indicated that the diagnostic models based on N-glycan markers are valuable and noninvasive alternatives for identifying GC. We concluded that decreased core-fucosylation in both tissue and serum from GC patients may result from the decreased expression of fucosyltransferase.

Decreased Core-Fucosylation Contributes to Malignancy in Gastric Cancer

The identification and characterization of novel N-glycan-based biomarkers in gastric cancer

Polypeptide N -acetylgalactosaminyltransferase-6 expression in gastric cancer.

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Identification of Aberrantly Expressed Glycans in Gastric Cancer by Integrated Lectin Microarray and Mass Spectrometric Analyses.

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Establishment and evaluation of new N-glycan biomarkers for diagnosis of gastric cancer

The Expression of Core Fucosylated E-cadherin in Cancer Cells and Lung Cancer Patients: Prognostic Implications

New Progress of Glycoprotein Glycans Associated With Gastric Cancer

Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling.

Core 1-Derived Mucin-Type O-Glycosylation Protects Against Spontaneous Gastritis And Gastric Cancer

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment

Integrated Glycome Strategy for Characterization of Aberrant LacNAc Contained N-Glycans Associated with Gastric Carcinoma.

Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation

Alterations of Fucosyltransferase Genes and Fucosylated Glycans in Gastric Epithelial Cells Infected with <i>Helicobacter pylori</i>

Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment

Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines

Upregulation of Family with Sequence Similarity 83 Member D Expression Enhances Cell Proliferation and Motility Via Activation of Wnt/β-catenin Signaling and Predicts Poor Prognosis in Gastric Cancer

Focal Adhesion-Related Signatures Predict the Treatment Efficacy of Chemotherapy and Prognosis in Patients with Gastric Cancer.